News

Both the parties will work together to strenthen the commercial position of Probi brand in the region. Probi CEO Michael Oredsson said the agreement is an important opportunity

The facility follows BASF’s acquisition of controlling stake in Lewis based Equateq, a technology company in lipid chemistry and pharmaceutical omega-3 fatty acid production. Scotland First Minister, Alex

Studies primary investigator George Peoples said new treatment options are needed to address unmet medical needs for breast cancer patients with HER2 low-to-intermediate expression or IHC 1+/2+ disease.

Meningitec preservative free vaccine is intended to treat N. meningitidis, an infectious disease which occurs majority in children, and can lead to meningitis, sepsis and pneumonia. Nuron Biotech

As part of the grant, UNITAID granted around $34m to the Medicines for Malaria Venture to accelerate the adoption of injectable artesunate for treating 8 million annual cases

The investigational drug has established a significant pain relief compared with placebo in the multi-centre study that randomized 462 patients with either submicron indomethacin, celecoxib or placebo. Iroko

As part of the partnership, Leica’s Bond Oracle HER2 IHC System companion diagnostic will be used in choosing eligible patients for the NeuVax phase 3 PRESENT (Prevention of

The patented MidNite works naturally to allow the usual sleep cycle to take over and contains a complex of natural herbs in addition to identical substances produced by

Pursuant to the deal signed between the two companies, Dr. Reddy’s has exclusive commercialization rights for the product, which will be exported from Debio Recherche Pharmaceutique, in India.